Recap: Avanos Medical Q1 Earnings

Avanos Medical (NYSE:AVNS) reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM. Here’s what…

Avanos Medical (NYSE:AVNS) reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Avanos Medical reported in-line EPS of $0.27 versus an estimate of $0.27.

Revenue was down $5.70 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 0.41% increase in the share price the next day.

Here’s a look at Avanos Medical’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.49 0.35 0.38 0.26
EPS Actual 0.60 0.38 0.41 0.26
Revenue Estimate 217.30M 205.47M 208.27M 197.80M
Revenue Actual 217.50M 202.10M 203.00M 197.40M

To track all earnings releases for Avanos Medical visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

IsoPlexis Announces Preliminary Unaudited Revenue For The Full Year Ended Dec 31, 2022 Total Revenue To Be In The Range Of $16.6M-$16.8M, Down 3%-4% YoY; Q4 Results Were Lower Than Expected Primarily Due To The Timing Of Customer Orders For Instruments

IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary unaudited revenue for the full year ended

ISO